Wei Xin (唯新)唯新
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 辽宁海神联盛制药有限公司Chinese legal name: 辽宁海神联盛制药有限公司
主要成分Active Ingredients
- 葛根素Gegen Su
药物知识说明
葛根素是一种在国家药监局注册认定的药品。该药品含有葛根素-29b34efa等成分。
该药品关联的活性成分包括：葛根素Gegen Su。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：辽宁海神联盛制药有限公司Chinese legal name: 辽宁海神联盛制药有限公司。
您可以探索含有相同成分的其他药品：葛根素-29b34efa成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 唯新) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 葛根素Gegen Su.
Manufacturers recorded for this product: 辽宁海神联盛制药有限公司Chinese legal name: 辽宁海神联盛制药有限公司.
Explore other medicines containing the same ingredient: 葛根素 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 唯新Recorded Chinese name: 唯新
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 250ml:葛根素0.6g与氯化钠2.2.gRecorded Chinese specification: 250ml:葛根素0.6g与氯化钠2.2.g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 辽宁海神联盛制药有限公司Chinese legal name: 辽宁海神联盛制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030649
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030649
Manufacturer
Chinese legal name: 辽宁海神联盛制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030649
生产企业
辽宁海神联盛制药有限公司(国产)
适应症
本品用于各型心绞痛、心肌梗塞、视网膜动静脉阻塞，突发性耳聋的治疗。
用法用量
1.用于新脑血管疾病时，常用量为：0.4~0.6/次，每日一次10~15天为一疗程。|2.用于眼底动、静脉阻塞和突发性耳聋时，常用量为：0.2~0.4/次，每日一次，10~22天为一疗程。
不良反应
1.个别病例用药开始时有暂时性腹胀、恶心等消化道反应，继续用药自行消失。|2.极少数病人可出现皮疹及发热。
禁忌
1.有明显出血倾向者慎用。|2.血容量不足者应在短期内补足血容量后使用本品。|3.需要低钠者，请勿使用。
注意事项
1.有出血倾向者慎用。|2.血容量不足者应在短期内补足血容量后使用本品。|3.本品使用前请详细检查，如有溶液混浊、封口松动、瓶身裂纹者，请勿使用。|4.需要限制钠摄入量的患者慎用。|5.使用本品者应定期监测胆红素、网织红细胞、血红蛋白及尿常规。|6.出现寒战、发热、黄疸、腰痛、尿色加深等症状者，需立即停药，及时治疗。|7.本品遇冷可能析出结晶，故在冬天应注意贮存条件，如出现结晶可将本品置于温水中，待结晶溶解后仍可使用。
规格
250ml:葛根素0.6g与氯化钠2.2.g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.